Along this line, two different scores have been recently introduced, and currently, they represent the gold standard for PD‐L1 evaluation in certain solid malignancies, including gastrointestinal cancer, non‐small cell lung cancer, as well as head and neck squamous cell carcinoma (Cohen et al., 2019; Paolino et al., 2021). The gene discussed is CD274; the disease is lung cancer.